Account
Hero background pattern

We’ll launch your pharmaceuticals to new heights

Specialist and experienced pricing and market access consultancy

News

ISPOR Europe 2023

We’re thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We’ll…
Read more
Insider Insights

Worldwide: New Coalition to improve access to canc…

According to the UICC, “priority will be given to medicines currently on the WHO Essential Medicin…
Read more
Insider Insights

World’s first CRISPR medicine approved in UK for…

The MHRA grants conditional approval to Casgevy, the first-ever CRISPR gene-editing therapy for sick…
Read more
Articles

World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H…
Read more
161 Pharma & biotech companies worked with
11 We work with 11 of the top 20 pharma companies
95% Positive feedback from our training courses
57 We’ve supported pricing and access strategies in 57 countries worldwide

Our Services

From launching your product to access training

Launch Implementation

We will develop and implement a successful launch strategy for your product.

Find out more

Price Optimization

We build payer focussed pricing and market access strategies to enable commercial success.

Find out more

Market Access Training

We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.

Find out more

Our mission

To enable patient access to your products

Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.

Our strategy

We have the expertise to get your products into doctors hands

Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.

How we work

Bespoke approach

Individual solutions to suit you

Flexible

We adapt our working style to reflect your needs

Real-world pharma experience

We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies

Responsive

We react quickly and effectively to provide the best support possible

Updates & News

Latest research and publications

News
16.11.2023
ISPOR Europe 2023

We’re thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We’ll…

Read more
Insider Insights
22.11.2023
AIFA reform set to move forward after receiving th…

AIFA reform is a landmark change which propels Italy towards expedited drug approvals and improved a…

Read more
Insider Insights
21.11.2023
World’s first CRISPR medicine approved in UK for…

The MHRA grants conditional approval to Casgevy, the first-ever CRISPR gene-editing therapy for sick…

Read more
Insider Insights
21.11.2023
Landmark deal reached on UK voluntary rebate schem…

Government, NHS, and Pharma Industry Unveil Successor to Voluntary Scheme for Branded Medicines Pric…

Read more
Articles
01.11.2023
World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H…

Read more
Webinar
31.10.2023
NICE’s Proportionate Approach to Technology …

Webinar: Our experts discuss NICE’s proportionate approach to technology appraisals and the implicat…

Read more
Publications
25.10.2023
ISPOR Europe 2023: Are Acute Therapies And Curativ…

We’ve updated our 2019 analysis which compares the annual and lifetime treatment costs of the 10 mos…

Read more
Publications
25.10.2023
ISPOR Europe 2023: Can Just Three PICOs be Feasibl…

This research aims to understand if just three PICOs are feasible by analysing recent HTA assessment…

Read more
Publications
25.10.2023
ISPOR Europe 2023: How Aware Are Biotech and Pharm…

Our research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in…

Read more
Visit our resource library

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.